Tear fluid and complement activation products in tears after ocular surgery.
Complement activation products
Inflammation
Ocular surface
Schirmer’s test
Tear
Tears
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
18 Jul 2023
18 Jul 2023
Historique:
received:
23
01
2023
accepted:
11
06
2023
medline:
21
7
2023
pubmed:
19
7
2023
entrez:
18
7
2023
Statut:
epublish
Résumé
Due to technological advancements, surgical invasiveness has been reduced. However, cataract surgery has been implicated in causing postoperative inflammation, including dry eye syndrome. The innate immune system may be involved in postoperative inflammation, and complement activation could potentially play a crucial role in defense against pathogens, homeostasis, and wound healing. To investigate changes in the tear film complement activation products (CAPs) and ocular surface after vitrectomy combined with cataract surgery. Forty-three patients (23 women; median age, 69 years) were enrolled in this prospective study and underwent phacoemulsification and vitrectomy. We measured Schirmer's test (ST) and CAPs in the tears at baseline (the day before surgery), 4 days and 1 month after the surgery. Tears were collected in microtubes. The CAPs in the tear fluid were analyzed by cytometric bead array. The median ST (8.5 mm) at baseline increased to 16 mm at 4 days ( P < 0.001) and 10 mm at 1 month (P = 0.44). The C3a levels (1202 pg/ml) at baseline increased to 2753 pg/ml at 4 days (P < 0.001), and 1763 pg/ml at 1 month (P = 0.049). The C4a levels (476 pg/ml) at baseline increased to 880 pg/ml at 4 days (P < 0.001), and 657 pg/ml at 1 month (P = 0.013). The C5a levels (22.6 pg/ml) at baseline increased to 470.9 pg/ml at 4 days (P < 0.001), and 38.3 pg/ml at 1 month (P = 0.0048). The surgical eyes were divided into the short ST group (≦ 10 mm, n = 22) and long ST group (> 10 mm, n = 21) based on the preoperative ST values. At 1 month postoperatively, the C3a levels were 2194 pg/ml in the preoperative short ST group and 1391 pg/ml in the long ST group, with significantly higher C3a concentrations in the short ST group (P < 0.001). The CAPs levels in tears increased after vitrectomy combined with cataract surgery. A preoperative deficit in tear secretion might induce prolonged complement activation and delayed recovery of ocular surface parameters postoperatively.
Identifiants
pubmed: 37464366
doi: 10.1186/s12886-023-03037-6
pii: 10.1186/s12886-023-03037-6
pmc: PMC10355014
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
329Informations de copyright
© 2023. The Author(s).
Références
Sci Rep. 2014 Aug 27;4:5772
pubmed: 25159733
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2085-93
pubmed: 19892865
Exp Eye Res. 2021 Feb;203:108402
pubmed: 33326809
Int J Mol Sci. 2019 Aug 01;20(15):
pubmed: 31374809
Bioessays. 1995 Feb;17(2):109-17
pubmed: 7748161
Ocul Surf. 2017 Jul;15(3):511-538
pubmed: 28736341
Sci Rep. 2021 Apr 19;11(1):8464
pubmed: 33875685
Am J Pathol. 1975 Jan;78(1):71-100
pubmed: 1109560
Acta Otolaryngol Suppl. 1993;501:88-91
pubmed: 8447233
Cornea. 2008 Aug;27(7):855
pubmed: 18650678
Proc Natl Acad Sci U S A. 2005 May 17;102(20):7227-32
pubmed: 15870199
Immunol Rev. 2004 Apr;198:185-202
pubmed: 15199963
Science. 2005 Apr 15;308(5720):385-9
pubmed: 15761122
Exp Eye Res. 1983 Mar;36(3):403-14
pubmed: 6601020
Ophthalmic Res. 2020;63(3):252-258
pubmed: 31645047
Am J Ophthalmol. 2019 Nov;207:410-418
pubmed: 30851269
J Immunol. 1985 Feb;134(2):1115-9
pubmed: 3871207
PLoS One. 2012;7(5):e36451
pubmed: 22590547
Jpn J Ophthalmol. 2020 Jul;64(4):429-436
pubmed: 32495157
Br J Surg. 1998 Apr;85(4):444-60
pubmed: 9607524
Am J Ophthalmol. 2019 Jun;202:47-54
pubmed: 30721689
J Clin Invest. 1994 Sep;94(3):1147-55
pubmed: 7521884
Cornea. 2007 Oct;26(9 Suppl 1):S16-20
pubmed: 17881910
J Cataract Refract Surg. 2019 May;45(5):669-684
pubmed: 31030780
Invest Ophthalmol Vis Sci. 2013 Mar 28;54(3):2385-92
pubmed: 23425692
Proc Natl Acad Sci U S A. 1983 Nov;80(21):6647-51
pubmed: 6415654
J Glob Health. 2018 Dec;8(2):020503
pubmed: 30206477
Surv Ophthalmol. 2021 Jul-Aug;66(4):594-611
pubmed: 33422510
J Allergy Clin Immunol. 1985 Sep;76(3):473-6
pubmed: 3875643
J Proteome Res. 2019 May 3;18(5):2321-2330
pubmed: 30966751
Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):39
pubmed: 33252634